Recombinant Speothos venaticus Cytochrome c oxidase subunit 2 (MT-CO2)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we will prioritize shipping the format currently in stock, please specify your format preference in order notes for customized fulfillment.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires advance notice and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and serves as a guideline.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer components, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The specific tag type is determined during production. If you require a particular tag, please specify this in your order for prioritized development.
Synonyms
MT-CO2; COII; COX2; COXII; MTCO2; Cytochrome c oxidase subunit 2; Cytochrome c oxidase polypeptide II
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-227
Protein Length
full length protein
Species
Speothos venaticus (Bush dog)
Target Names
Target Protein Sequence
MAYPFQLGLQDATSPIMEELLHFHDHTLMIVFLISSLVLYIISSMLTTKLTHTSTMDAQE VETVWTILPAIILVLIALPSLRILYMMDEINNPSLTVKTLGHQWYWSYEYTDYEDLNFDS YMIPTQELKPGELRLLEVDNRVVLPMEMTIRMLISSEDVLHSWAVPSLGLKTDAIPGRLN QTTLMATRPGLYYGQCSEICGSNHSFMPIVLEMVPLSYFETWSALML
Uniprot No.

Target Background

Function
Cytochrome c oxidase subunit 2 (MT-CO2) is a component of cytochrome c oxidase (complex IV, CIV), the terminal enzyme in the mitochondrial electron transport chain responsible for oxidative phosphorylation. This chain comprises three multi-subunit complexes: succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (complex III, CIII), and cytochrome c oxidase (CIV). These complexes cooperate to transfer electrons from NADH and succinate to molecular oxygen, generating an electrochemical gradient across the inner mitochondrial membrane that drives ATP synthesis via ATP synthase. Cytochrome c oxidase catalyzes the reduction of oxygen to water. Electrons from reduced cytochrome c (in the intermembrane space) are transferred via the Cu(A) center (subunit 2) and heme a (subunit 1) to the binuclear center (BNC) in subunit 1 – a site comprising heme a3 and Cu(B). The BNC reduces molecular oxygen to two water molecules, utilizing four electrons from cytochrome c and four protons from the mitochondrial matrix.
Protein Families
Cytochrome c oxidase subunit 2 family
Subcellular Location
Mitochondrion inner membrane; Multi-pass membrane protein.

Q&A

What is Cytochrome c oxidase subunit 2 and what is its functional significance?

Cytochrome c oxidase subunit 2 (MT-CO2/COX2/COII) is a key component of cytochrome c oxidase (COX), the terminal enzyme in the mitochondrial electron transport chain. This protein is directly responsible for the initial transfer of electrons from cytochrome c to the COX complex, which is crucial for ATP production during cellular respiration . MT-CO2 is encoded by the mitochondrial genome and functions as part of Complex IV, which catalyzes the reduction of oxygen to water while contributing to the electrochemical gradient that drives ATP synthesis .

The functional significance of MT-CO2 extends beyond its catalytic role. Studies have identified specific structural features including a copper ion (CuA) binding site involving two cysteine and two histidine residues, four invariant acidic amino acid residues (two aspartic acid and two glutamic acid) potentially involved in cytochrome c interactions, and a conserved region of aromatic residues (Tyr-Gln-Trp-Tyr-Trp-Gly-Tyr-Glu-Tyr) hypothesized to participate in electron transfer . These structural elements are highly conserved across species, highlighting their importance in maintaining proper respiratory function.

What expression systems are most effective for producing recombinant MT-CO2?

For recombinant MT-CO2 production, E. coli expression systems have been successfully employed, as demonstrated with other species' MT-CO2 proteins . When working with Speothos venaticus MT-CO2, researchers should consider the following expression approaches:

Table 1: Comparison of Expression Systems for Recombinant MT-CO2

Expression SystemAdvantagesLimitationsRecommended Applications
E. coliHigh yield, cost-effective, rapid growthPotential issues with membrane protein folding, lack of post-translational modificationsInitial characterization, antibody production, protein-protein interaction studies
Yeast (P. pastoris/S. cerevisiae)Better folding for eukaryotic proteins, some post-translational modificationsLower yield than E. coli, longer expression timeFunctional studies requiring properly folded protein
Insect cellsSuperior folding and post-translational modificationsHigher cost, technical complexityStructural studies, enzymatic assays requiring native conformation
Mammalian cellsMost authentic post-translational modificationsHighest cost, lowest yield, most technically demandingStudies focusing on physiological relevance and regulatory modifications

For optimal expression in E. coli, the protocol should include an N-terminal His-tag for purification, careful optimization of induction conditions, and consideration of codon usage optimization for canid mitochondrial genes . After expression, purification typically involves Ni-NTA affinity chromatography followed by size exclusion techniques to ensure >90% purity as verified by SDS-PAGE.

How is MT-CO2 sequence conservation relevant to research on Speothos venaticus?

MT-CO2 exhibits notable sequence conservation across mammalian species due to its essential role in respiration, making comparative analyses particularly valuable. Studies of Tigriopus californicus demonstrated that while intrapopulation divergence at the COII locus was minimal, interpopulation divergence reached approximately 20% at the nucleotide level, including 38 nonsynonymous substitutions . This pattern likely extends to canid species, including Speothos venaticus.

When comparing MT-CO2 sequences across species, researchers should focus on:

  • Functionally critical regions like the CuA binding site, which shows high conservation (>95% identity) across mammals

  • Regions involved in cytochrome c interaction, which may exhibit species-specific adaptations

  • Transmembrane domains that anchor the protein within the inner mitochondrial membrane

  • Sites under positive selection that may reflect adaptation to different energetic demands

What are the optimal protocols for measuring cytochrome c oxidase activity in recombinant MT-CO2 preparations?

Accurate measurement of cytochrome c oxidase activity is essential for functional characterization of recombinant MT-CO2. A standardized assay protocol based on established methods includes:

  • Sample preparation: Microsomal fractions should be prepared by homogenizing samples in extraction buffer containing 10 mM HEPES (pH 7.5), 200 mM mannitol, 70 mM sucrose, 1 mM EGTA, and protease inhibitors (0.1 mM phenylmethyl-sulfonyl fluoride, 0.25 mM dibucaine, and 1 mM benzamidine) . The homogenate should be centrifuged at 600×g to remove cellular debris.

  • Activity measurement: Cytochrome c oxidase activity should be measured spectrophotometrically at 550 nm by monitoring the oxidation of reduced cytochrome c. The reaction mixture should contain 50 μM reduced cytochrome c in 10 mM potassium phosphate buffer (pH 7.0). The decrease in absorbance should be recorded at 25°C for 3 minutes.

  • Data analysis: Activity is calculated using the extinction coefficient of cytochrome c (21.84 mM⁻¹cm⁻¹) and expressed as nmol cytochrome c oxidized/min/mg protein. Results should be normalized to citrate synthase activity as a mitochondrial marker to account for differences in mitochondrial content .

  • Controls and validation: Include positive controls (commercial bovine heart cytochrome c oxidase) and negative controls (heat-inactivated samples) in each assay. Specificity can be confirmed by adding KCN (2 mM), which should inhibit >95% of the activity.

Table 2: Troubleshooting Guide for Cytochrome c Oxidase Activity Assays

IssuePotential CauseRecommended Solution
Low activityProtein denaturationUse fresh preparations; avoid freeze-thaw cycles
Improper reconstitutionEnsure proper lipid environment for membrane protein
Incomplete reduction of cytochrome cVerify >95% reduction with sodium dithionite
High backgroundAutooxidation of cytochrome cUse higher buffer pH; remove trace metals with EDTA
Non-specific oxidationInclude antimycin A to block complex III activity
Variable resultsTemperature fluctuationsStrictly maintain 25°C during measurements
Protein concentration variationsStandardize protein amount; use Bradford assay

How do point mutations in conserved regions affect MT-CO2 function and electron transfer efficiency?

Studies in other species have shown that mutations in the CuA binding site typically result in >90% reduction in electron transfer activity, while mutations in the cytochrome c interaction domain may reduce activity by 50-80% depending on the specific residue . Mutations in transmembrane regions often affect assembly of the complex rather than direct catalytic function.

What strategies can resolve expression and solubility challenges with recombinant MT-CO2?

Membrane proteins like MT-CO2 present significant challenges for recombinant expression. The following strategies can help overcome common issues:

  • Fusion protein approaches: Create fusion constructs with solubility-enhancing partners such as:

    • Thioredoxin (Trx)

    • Glutathione S-transferase (GST)

    • Maltose-binding protein (MBP)

    • SUMO (Small Ubiquitin-like Modifier)

  • Expression condition optimization: Systematically test various conditions including:

    • Reduced temperature (16-20°C) during induction

    • Lower IPTG concentrations (0.1-0.5 mM)

    • Extended expression periods (16-24 hours)

    • Rich vs. minimal media formulations

  • Detergent screening for extraction and purification: Test a panel of detergents including:

    • Mild non-ionic detergents (DDM, OG, Triton X-100)

    • Zwitterionic detergents (LDAO, CHAPS)

    • Newer amphipathic polymers (amphipols, SMALPs)

  • Co-expression with chaperones: Include molecular chaperones such as GroEL/GroES, DnaK/DnaJ/GrpE, or trigger factor to improve folding.

  • Refolding protocols: For inclusion body recovery, develop a refolding protocol:

    • Solubilize in 8M urea or 6M guanidine-HCl

    • Remove denaturant by dialysis with decreasing concentrations

    • Include stabilizing agents (glycerol, arginine, proline)

    • Add essential cofactors (copper) during refolding

For storage, avoid repeated freeze-thaw cycles and store working aliquots at 4°C for up to one week . Long-term storage should be at -80°C in buffer containing 6% trehalose to maintain stability .

How can researchers analyze interactions between recombinant MT-CO2 and other components of the respiratory chain?

Understanding the interactions between MT-CO2 and other components of the respiratory chain requires sophisticated biochemical and biophysical approaches:

  • Reconstitution systems: Develop proteoliposome systems containing:

    • Purified recombinant MT-CO2

    • Other COX subunits (particularly nuclear-encoded subunits)

    • Cytochrome c for functional studies

    • Cardiolipin and other essential phospholipids

  • Interaction analysis techniques:

    • Surface plasmon resonance (SPR) to measure binding kinetics with cytochrome c

    • Isothermal titration calorimetry (ITC) to determine thermodynamic parameters

    • Hydrogen-deuterium exchange mass spectrometry (HDX-MS) to map interaction interfaces

    • Förster resonance energy transfer (FRET) to monitor protein-protein interactions in real-time

  • Cross-linking coupled with mass spectrometry (XL-MS): Use chemical cross-linkers of varying lengths to identify:

    • Direct contact points between MT-CO2 and cytochrome c

    • Interactions with other COX subunits

    • Potential interactions with Complex III (cytochrome bc1)

  • Functional assays in reconstituted systems:

    • Measure electron transfer rates in the presence of varying concentrations of interaction partners

    • Assess the impact of mutations in either MT-CO2 or its binding partners

    • Evaluate the role of post-translational modifications on interaction efficiency

The respiratory chain contains three multisubunit complexes (Complex II, III, and IV) that cooperate to transfer electrons from NADH and succinate to molecular oxygen . MT-CO2 plays a critical role in this process by facilitating electron transfer from cytochrome c to the catalytic center of Complex IV.

What purification strategy yields the highest activity for recombinant MT-CO2?

Obtaining high-purity, active recombinant MT-CO2 requires a carefully optimized purification strategy:

Table 3: Multi-Step Purification Strategy for Recombinant MT-CO2

StepMethodBuffer CompositionCritical ParametersExpected Results
1. Cell lysisSonication or pressure homogenizationTris/PBS-based buffer (pH 8.0) with protease inhibitorsKeep samples cold (4°C); include 5-10% glycerolComplete cell disruption with minimal protein denaturation
2. Initial captureImmobilized metal affinity chromatography (IMAC)50 mM Tris, 300 mM NaCl, 10 mM imidazole, 0.1% detergent (pH 8.0)Choose appropriate detergent; gradual imidazole elution (20-250 mM)70-80% purity; removal of major contaminants
3. Intermediate purificationIon exchange chromatography20 mM Tris or phosphate buffer with 0.05% detergentOptimize pH based on protein pI; use salt gradient elution85-90% purity; separation from proteins with similar IMAC profiles
4. PolishingSize exclusion chromatographyPBS with 0.02% detergent, 5-10% glycerolRun at low flow rate; collect narrow fractions>90% purity with minimal aggregation
5. ConcentrationCentrifugal filtrationSame as size exclusion bufferUse appropriate MWCO; avoid excessive concentrationConcentrated protein (1-5 mg/ml) without precipitation

After purification, protein should be aliquoted to avoid freeze-thaw cycles and stored in a buffer containing 6% trehalose for stability . Quality control should include SDS-PAGE analysis, western blotting (using anti-His and anti-MT-CO2 antibodies), and activity assays to confirm both purity and functionality.

For reconstitution of active protein, incorporating the MT-CO2 into nanodiscs or liposomes with a native-like lipid composition (including cardiolipin) significantly improves stability and activity. The specific lipid composition can be optimized based on the native mitochondrial membrane composition of Speothos venaticus if available, or approximated using canine mitochondrial lipid profiles.

What antibody-based approaches are available for detecting and studying recombinant MT-CO2?

Several antibody-based approaches can be employed for detecting and studying recombinant MT-CO2:

  • Available antibody types:

    • Anti-tag antibodies (His-tag, etc.) for recombinant protein detection

    • Anti-MT-CO2 polyclonal antibodies with cross-reactivity to canid species

    • Anti-MT-CO2 monoclonal antibodies targeting conserved epitopes

    • Species-specific antibodies that may require custom development for Speothos venaticus

  • Applications and methodologies:

    • Western blotting: Use 1:1000-1:5000 dilution of primary antibody; optimize blocking conditions to reduce background

    • Immunohistochemistry (IHC): Typically requires antigen retrieval; 1:100-1:500 dilution range

    • Immunofluorescence (IF): Use fluorophore-conjugated secondary antibodies; include mitochondrial co-markers

    • Immunoprecipitation (IP): Optimize antibody:protein ratio; use magnetic beads for higher recovery

  • Epitope considerations:

    • N-terminal epitopes are often more accessible but may be blocked by fusion tags

    • Transmembrane regions make poor epitopes due to hydrophobicity and accessibility issues

    • The C-terminal domain contains conserved functional regions that can serve as useful epitope targets

    • Conformational epitopes often provide better specificity but require native protein conformation

  • Validation approaches:

    • Positive controls using commercial cytochrome c oxidase preparations

    • Negative controls with other mitochondrial proteins

    • Peptide competition assays to confirm specificity

    • Knockout/knockdown validation where possible

Many commercial antibodies against cytochrome c oxidase subunits show cross-reactivity across species due to sequence conservation. When selecting antibodies, researchers should verify cross-reactivity with canid species or closely related mammals if Speothos venaticus-specific antibodies are unavailable .

How can researchers identify post-translational modifications in recombinant MT-CO2?

Identifying post-translational modifications (PTMs) in recombinant MT-CO2 requires sophisticated analytical approaches:

  • Mass spectrometry-based methods:

    • Bottom-up proteomics: Enzymatic digestion followed by LC-MS/MS analysis

    • Top-down proteomics: Analysis of intact protein to preserve modification patterns

    • Targeted MS approaches: Multiple reaction monitoring (MRM) for specific modifications

    • Enrichment strategies: IMAC for phosphorylation, lectin affinity for glycosylation

  • Modification-specific analytical approaches:

    • Phosphorylation: Pro-Q Diamond staining, phospho-specific antibodies, phos-tag SDS-PAGE

    • Oxidative modifications: OxyBlot, redox proteomics approaches

    • Metal binding: Inductively coupled plasma mass spectrometry (ICP-MS) to quantify copper content

    • Protein-lipid interactions: Thin-layer chromatography after lipid extraction

  • Functional impact assessment:

    • Site-directed mutagenesis to mimic or prevent modifications

    • Activity assays comparing modified and unmodified protein forms

    • Structural analysis to determine how modifications affect protein conformation

    • Interaction studies to assess effects on binding to other respiratory chain components

  • Bioinformatic prediction and analysis:

    • PTM prediction algorithms (NetPhos, GPS, etc.) to identify potential modification sites

    • Structural modeling to assess accessibility of predicted sites

    • Evolutionary conservation analysis of modification sites across species

    • Integration of PTM data with functional domains and interaction interfaces

Common modifications in MT-CO2 include phosphorylation of serine/threonine residues that may regulate activity, oxidative modifications that can indicate damage and altered function, and metal-binding modifications critical for electron transfer function.

What biophysical techniques are most informative for structural characterization of recombinant MT-CO2?

Structural characterization of recombinant MT-CO2 requires a combination of complementary biophysical techniques:

  • Spectroscopic methods:

    • Circular dichroism (CD): Provides information on secondary structure content and stability

    • Fluorescence spectroscopy: Monitors tertiary structure through intrinsic tryptophan fluorescence

    • FTIR spectroscopy: Particularly useful for analyzing membrane proteins in lipid environments

    • EPR spectroscopy: Specifically informative for studying the copper centers in MT-CO2

  • Hydrodynamic techniques:

    • Analytical ultracentrifugation (AUC): Determines oligomeric state and homogeneity

    • Dynamic light scattering (DLS): Assesses size distribution and aggregation propensity

    • Size exclusion chromatography with multi-angle light scattering (SEC-MALS): Provides absolute molecular weight

  • High-resolution structural methods:

    • X-ray crystallography: Requires well-diffracting crystals; challenging for membrane proteins

    • Cryo-electron microscopy: Increasingly powerful for membrane protein complexes

    • NMR spectroscopy: Most applicable to specific domains rather than the entire protein

    • Hydrogen-deuterium exchange mass spectrometry (HDX-MS): Maps solvent-accessible regions

  • Computational approaches:

    • Homology modeling: Based on structures of MT-CO2 from other species

    • Molecular dynamics simulations: Explores conformational dynamics in membrane environment

    • Integrative modeling: Combines experimental constraints from multiple low-resolution techniques

For membrane proteins like MT-CO2, structural characterization in a native-like lipid environment is crucial. Techniques such as EPR spectroscopy can provide specific information about the copper centers that are essential for electron transfer function , while HDX-MS can map interactions with other subunits and cytochrome c.

What are the most promising future research directions for Speothos venaticus MT-CO2?

Future research on Speothos venaticus MT-CO2 offers several promising directions that could advance our understanding of both basic mitochondrial biology and species-specific adaptations:

  • Comparative genomics and evolution: Analyzing MT-CO2 sequence variation across canid species could reveal adaptive changes related to the bush dog's unique ecological niche and hunting behaviors. Studies in other species have shown that approximately 4% of COII codons evolve under relaxed selective constraint (ω = 1), while the majority are under strong purifying selection .

  • Structure-function relationships: Detailed characterization of the structure-function relationship in bush dog MT-CO2 could identify species-specific features that optimize energy production for their lifestyle. This could include adaptation to different temperature ranges or metabolic demands.

  • Mitochondrial-nuclear genome co-evolution: Investigation of interactions between MT-CO2 and nuclear-encoded subunits could reveal co-evolutionary patterns specific to Speothos venaticus. Previous studies have identified positive selection in COII codons that may compensate for amino acid substitutions in other subunits .

  • Disease models and conservation implications: Understanding the functional properties of MT-CO2 could provide insights into potential mitochondrial diseases in canids and inform conservation efforts for this near-threatened species.

  • Biotechnological applications: The unique properties of Speothos venaticus MT-CO2 might be leveraged for applications in bioenergetics, biosensors, or enzyme engineering, particularly if it exhibits advantageous stability or activity characteristics.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.